Several common pulmonary disorders characterized by mucus hypersecretion and airway obstruction may relate to increased levels of inhaled or endogenously generated oxidants (02 metabolites) in the respiratory tract. We found that 02 metabolites stimulated release of high-molecular-weight glycoconjugates (HMG) by respiratory epithelial cells in vitro through a mechanism involving cyclooxygenase metabolism of arachidonic acid. 
Introduction
Mucus hypersecretion characterizes a number of common pulmonary disorders associated with exposure to inhaled or endogenously generated oxidants. Inhalation of cigarette smoke (1), particulate (2) and gaseous (3) air pollutants, and hyperoxia (4) cause mucus hypersecretion and have been suspected to increase the oxidant load on respiratory epithelium. In addition, locally increased levels ofchemotaxins and mediators of inflammation (5) Receivedfor publication 25 January 1989 and in revisedform 22 August 1989. metabolites from recruited neutrophils and mononuclear phagocytes. Toxic 02 metabolites can induce a spectrum of lesions in the respiratory tract, as well as pulmonary vasculature and parenchyma, and have been associated with acute lung injury, permeability edema, airways hyperreactivity, small airways disease, endothelial injury, vasoconstriction, adult respiratory distress syndrome, and fibrosis (6) (7) (8) .
Hypersecretion of respiratory mucus also occurs after inhalation of noxious gaseous (9) and particulate (10) material, as well as in response to endogenous mediators of inflammation (1 1). A key to modulating an association between oxidant stress and mucus hypersecretion could be activation of arachidonic acid metabolism within airway epithelium. Reactive oxygen species can provoke release of arachidonic acid from membrane phospholipids and activate both the cyclooxygenase and lipoxygenase metabolic pathways (12) . Thus, exposure to 02 metabolites could lead to increased synthesis of several bioactive eicosanoids which, in turn, could stimulate secretion of airway mucus (13) . Conversely, a "by-product" of both cyclooxygenase and lipoxygenase metabolism of arachidonic acid could be production of toxic oxygen species intracellularly (14) . These suggested interactions led us to postulate that 02 metabolites could stimulate release of mucinlike glycoproteins from respiratory epithelium through a mechanism involving metabolism of arachidonic acid.
The purpose of our studies was to determine if and how oxidant exposure stimulates release ofmucinlike glycoproteins by airway epithelium. To address these questions, the effects of chemically (enzymatically)-generated 02 metabolites on secretion/release of high-molecular-weight glycoconjugates (HMG)' was examined in organotypic primary cultures of guinea pig tracheal epithelial cells (15, 16) and in organ cultures (explants) of guinea pig and rabbit trachea (1 1).
Methods
Sources of reagents. Healthy, infection-free guinea pigs (200-250 g VAF/+ Hartley males) or rabbits (2 kg New Zealand White males) were purchased from Charles River Breeding Laboratories, Inc., Wilmington, MA. Waymouth's MB 752/1 medium, gentamycin, nystatin and Hanks' balanced salts solution (HBSS) were obtained from Gibco Laboratories, Grand Island, NY. Dazoxiben was a generous gift from Hoffmann La Roche, Inc., Nutley, NJ. Xanthine oxidase isolated from bovine milk without use of proteases (17) was kindly donated by Dr. Joe M. McCord, University of South Alabama, Mobile, AL. PC-1 medium was bought from Ventrex Corp., Portland, ME. Cell culture chambers were constructed as described previously (16) [5, 6, 8, 9 ,1 l,12,14,15-3H(N)], sp act 60-100 Ci/mmol, were purchased from New England Nuclear, Boston, MA. All other chemicals, including purine, xanthine, xanthine oxidase (XO), fl-D-glucose, glucose oxidase (GO), indomethacin, nordihydroguiaretic acid (NDGA), superoxide dismutase (SOD), catalase (CAT), polyethylene glycol (PEG) and PEG-conjugated catalase (PEG-CAT), mannitol, dimethylthiourea (DMTU), ovine testicular hyaluronidase (type VI-S), cytochrome c, sodium azide, ammonium sulfate, and potassium thiocyanate, were purchased from Sigma Chemical Co., St. Louis, MO.
Organotypic culture ofrespiratory epithelial cells. Primary airway epithelial cells were cultured utilizing an organotypic culture system developed in this laboratory (15, 16) . Briefly, tracheal epithelial cells were dissociated enzymatically from excised guinea pig airways, washed, and placed on a collagen gel atop a microporous membrane. Cells were cultured with PC-l medium (without serum, containing gentamycin (50 ,ug/ml] and nystatin [20 U/ml]; changed every 2 d) beneath the cells only, with a humidified atmosphere of 95% air/5% CO2 maintained above the cells.
Organ culture oftracheal explants. Organ cultures ofguinea pig and rabbit tracheal explants were conducted as described (1 1). Explants were rocked at 5 cycles/min at 100% humidity in 95% air/5% CO2 at 37°C in 0.5 ml of serumless Wayhiouth's MB 752/1 medium containing 100 gg/ml gentamycin and 25 U/ml nystatin.
Collection and measurement of released HMG. 8-d cultures were incubated for 18 h in glucose-free PC-l medium containing 15 tCi/ml tritiated glucosamine-HCl. Subsequently, radiolabeled medium was replaced with fresh unlabeled medium. After incubation for 2 h (baseline period), apical surfaces ofthe cultures were rinsed with HBSS, and collected for analysis of secreted HMG. Subsequently, cells were incubated with specific test substances (e.g., purine and XO; see below) or paired controls consisting of medium (plus solubilization vehicle, when used) without test substance for a 1-h (experimental) period, at which time the apical washings were collected.
Baseline and experimental period media + washings were assayed for released glycoconjugates using chromatography on Sepharose CL-4B columns (16, 18, 19) . Briefly, samples were adjusted to pH 5.0 using 0.1 M citric acid and then treated with 100 U/ml ovine testicular hyaluronidase at 37°C for 18 h. Subsequently, the mixture was adjusted to neutral pH (7.4) with 0.2 M NaOH, placed in a boiling water bath for 5 min, and centrifuged at low speed. Supernatants were collected and applied to i X 50-cm columns of Sepharose CL-4B equilibrated with PBS containing 0.1% (wt/vol) sodium dodecyl sulfate (SDS). Columns then were eluted with this buffer at a constant flow rate of 1 ml/min and fractions of 1.5 ml collected and mixed with 6 ml of Optifluor. Disintegrations per minute were counted by liquid scintillation. The sum of radioactivity in the five peak fractions of the excluded void volume was defined as the amount of HMG in the sample (20) . Released glycoconjugates for each experiment were measured as the ratio of experimental to baseline values and expressed as percentage of control (control = experimental/baseline for medium alone or medium plus vehicle) as described (21) .
In another study reported elsewhere, we analyzed the void volume material eluting from these columns to investigate its composition (22 (24) . LDH was measured spectrophotometrically at 525 nm using a commercially purchased kit (Sigma kit no 500).
Generation of02 metabolites. Superoxide anion (°2) was generated extracellularly by addition of XO to purine over a range of concentrations (7) . Hydrogen peroxide (H202) was generated by addition of GO to ,-D-glucose (1%) (7, 8 (26) .
Assay of arachidonic acid metabolites by high performance liquid chromatography (HPLC). Cell cultures were incubated for 2 h at 37°C with S ,uCi/ml tritiated arachidonic acid together with 10-9 M unlabeled arachidonic acid (27) . After incubation, cultures were washed extensively with HBSS and placed into fresh, unlabeled control medium or unlabeled medium containing purine (0.2 mM) + XO (0.02 U/ml). Cultures then were incubated for 2 h at 37°C, at which time media from eight separate cultures were pooled. After centrifugation at 2000 rpm for 10 min at 4°C, supernatants were placed in 50-ml tubes to which 16 ml of 100% ethanol (-20°C) was added before recentrifugation at 2,500 rpm for 20 
Results
Effects of 02 metabolites on release ofHMG. Addition of increasing concentrations of XO to purine progressively increased release of HMG by cultured respiratory epithelial cells ( Fig. 1 ) and tracheal explants ( + XO-treated samples (Fig. 3) . In addition, release of LDH by purine + XO-exposed cells was similar to control cells: control cultures released 5.37±1.1% of total (cell + medium) LDH compared with 7.44±2.3% of total for 02 metabolite-exposed cells (Total LDH in control and 02 metabolite-exposed cells per milligram of protein were nearly identical.) Thus, 02 metabolites appeared to stimulate release of HMG without causing overt cellular damage or lysis.
Effects of scavengers on 02 metabolite-stimulated HMG release. Addition of SOD, PEG-CAT, or DMTU inhibited the stimulatory effects of purine + XO on HMG release in both cell (Fig. 4 ) and organ cultures (Fig. 5) Effects of02 metabolite scavengers or arachidonic acid metabolism inhibitors on PGF2a production. As illustrated in Table II , addition of purine + XO increased production of PGFu by cell cultures. Purine + XO-induced increases in PGF2a were inhibited by coaddition of PEG-CAT, DMTU, NDGA, or indomethacin. In contrast, addition of mannitol or CAT not bound to PEG did not inhibit 02 metabolite-stimulated increases in production of PGF2a, a finding which corresponded to the lack of effect of these agents on 02 metabolitestimulated HMG release (Fig. 4) .
Discussion
We found that 02 metabolites generated extracellularly by purine + XO provoked a concentration-dependent stimula Enhanced release of HMG did not appear related to a nonspecific toxic response to the 02 metabolites. Ultrastructural examination of explants and cell cultures after exposure to stimulatory concentrations of purine + XO did not reveal morphological signs of toxicity, such as membrane blebbing, cell swelling, and/or vacuolization in the epithelial cells. In addition, release of LDH, a marker of cytotoxicity, was not increased after incubation with 02 metabolites for 1 h. Thus, 02 metabolite-mediated HMG release appeared to be an active phenomenon, and not merely a passive leakage of cellular contents due to nonspecific cellular lysis.
The cellular source(s) of the released HMG could not be determined from these experiments. It has been reported that macromolecular secretions in the airway lumen can originate from several cellular locations, such as the glycocalyx of surface-ciliated and secretory cells, and/or intracellular granules (20) . Material from intracellular origins and cell surfaces both can be released upon appropriate stimulation, including exocytosis, cell surface shedding, and exposure to external stimuli, such as proteases (20) . Accordingly, 02 metabolites could have stimulated release of both cell surface-associated and intracellular HMG.
Although (31) . Since PEG-CAT has both H202-and -OH-scavenging properties, one possible interpretation is that exposure of respiratory epithelial cells to extracellularly generated 02 metabolites may stimulate production of oxygen free radicals intracellularly, and it is these intracellularly generated active oxygen species which act to provoke HMG release. In support ofthis concept, HMG release also was inhibited after addition ofthe permeant H202 and * OH scavenger, DMTU, but not by addition of the relatively weak and impermeable * OH scavenger, mannitol (32) . Thus, it would appear that intracellular production or (14) , and, conversely, intracellular 02 metabolites stimulate arachidonic acid release and metabolism (34) . However, these theoretical considerations do not alter the findings reported here that indicate epithelial-derived PGFA is a major contributor to respiratory HMG release after exposure to 02 metabolites. PGF2. is a major cyclooxygenase product of respiratory epithelium in several species (27) 
